Activity

Filter

Cancel
Date Panel Item Activity
6 actions
Genetic Epilepsy v0.1123 PPP2R1A Zornitza Stark Phenotypes for gene: PPP2R1A were changed from Mental retardation, autosomal dominant 36 MIM#616362 to Mental retardation, autosomal dominant 36, MIM#616362; Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome, MONDO:0014605
Genetic Epilepsy v0.1122 PPP2R1A Zornitza Stark Marked gene: PPP2R1A as ready
Genetic Epilepsy v0.1122 PPP2R1A Zornitza Stark Gene: ppp2r1a has been classified as Green List (High Evidence).
Genetic Epilepsy v0.1122 PPP2R1A Zornitza Stark Classified gene: PPP2R1A as Green List (high evidence)
Genetic Epilepsy v0.1122 PPP2R1A Zornitza Stark Gene: ppp2r1a has been classified as Green List (High Evidence).
Genetic Epilepsy v0.1121 PPP2R1A Elena Savva gene: PPP2R1A was added
gene: PPP2R1A was added to Genetic Epilepsy. Sources: Literature
Mode of inheritance for gene: PPP2R1A was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Publications for gene: PPP2R1A were set to PMID: 33106617; 26168268
Phenotypes for gene: PPP2R1A were set to Mental retardation, autosomal dominant 36 MIM#616362
Mode of pathogenicity for gene: PPP2R1A was set to Other
Review for gene: PPP2R1A was set to GREEN
Added comment: Likely dominant negative. For some variants, binding assays using HEK293T cells transfected with either WT or mutant constructs demonstrated decreased binding to B subunit families or C subunit with corresponding decrease in PP2A activity by affecting the trimeric holoenzyme (hypothesized by authors) ((PMIDs: 26168268, 33106617).

10/26 patients were reported with epilepsy, interestingly none also presented with macrocephaly (otherwise observed in 38% of the cohort)
Sources: Literature